02 1月 2018 by admin in UncategorizedComments Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
30 11月 2017 by admin in UncategorizedComments resTORbio Raises $40 Million to Advance Selective TORC1 Inhibitors for Aging-Related Diseases and Conditions
11 11月 2017 by admin in UncategorizedComments How Quan Plans To Deploy Its Inaugural $150m Healthcare Fund
29 8月 2017 by admin in UncategorizedComments ARMO BioSciences Raises $67 Million in a Series C-1 Financing
